Abstract
As donor and donor organ characteristics affect all solid organ recipient outcomes, careful evaluation is essential. In heart transplantation, further aspects are also crucial: donor age (and the last 10 years have seen a notable increase in mean donor age) and potentially negative effects on the heart of brain-death pathophysiologic consequences in brain-dead donors. It is becoming increasingly clear that donor parameters are a major factor in post-transplant mortality, as much as recipient characteristics. Consequently the decision as to whether to accept a heart comes at the end of a complex process.
This chapter reviews the main principles guiding the decision-making on donor heart suitability for transplantation and gives insight into pathology evaluation of donor hearts and the pathological abnormalities that can be found there.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abuanzeh R, Hashmi F, Dimarakis I, Khasati N, Machaal A, Yonan N, Venkateswaran RV. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors. Eur J Cardiothorac Surg. 2015;47(1):72–7; discussion 77.
Ali AA, Lim E, Thanikachalam M, Sudarshan C, White P, Parameshwar J, Dhital K, Large SR. Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation. Eur J Cardiothorac Surg. 2007;31(5):929–33.
Balaz P, Rokosny S, Wohlfahrtova M, Wohlfahrt P, Bartonova A, Pokorna E, Honsova E, Viklicky O. Identification of expanded-criteria donor kidney grafts at lower risk of delayed graft function. Transplantation. 2013;96(7):633–8.
Berman M, Ali A, Ashley E, Freed D, Clarke K, Tsui S, Parameshwar J, Large S. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant. 2010;29(9):957–65.
Bombardini T, Gherardi S, Arpesella G, Maccherini M, Serra W, Magnani G, Del Bene R, Picano E. Favorable short-term outcome of transplanted hearts selected from marginal donors by pharmacological stress echocardiography. J Am Soc Echocardiogr. 2011;24(4):353–62.
Bombardini T, Arpesella G, Maccherini M, Procaccio F, Potena L, Bernazzali S, Leone O, Picano E. Medium-term outcome of recipients of marginal donor hearts selected with new stress-echocardiographic techniques over standard criteria. Cardiovasc Ultrasound. 2014;12:20–7.
Burke A, Tavora F, editors. Hypersensivity and toxic myocarditis, chap. 23. In: Practical cardiovascular pathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 249.
Caforio AL, Tona F, Fortina AB, Angelini A, Piaserico S, Gambino A, Feltrin G, Ramondo A, Valente M, Iliceto S, Thiene G, Gerosa G. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant. 2004;4(6):962–70.
Casartelli M, Bombardini T, Simion D, Gaspari MG, Procaccio F. Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart. Cardiovasc Ultrasound. 2012;10:25–32.
Dark JH. Safe and effective use of the extended donor heart. Eur J Cardiothorac Surg. 2015;47(1):78–9.
Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. Br J Surg. 2014;101(7):768–74.
Doroshow RW, Ashwal S, Saukel GW. Availability and selection of donors for pediatric heart transplantation. J Heart Lung Transplant. 1995;14(1 Pt 1):52–8.
Dronavalli VB, Banner NR, Bonser RS. Assessment of the potential heart donor: a role for biomarkers? J Am Coll Cardiol. 2010;56:352–61.
Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, Freeman RB, Belghiti J. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694–707.
D’Alessandro AM, Kalayoglu M, Sollinger HW, Hoffman RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation. 1991;51:157–63.
Eskandary FA, Kohl M, Dunkler D, Aliabadi A, Grommer M, Schiferer A, Gokler J, Wieselthaler G, Laufer G, Zuckermann A. Lack of donor and recipient age interaction in cardiac transplantation. J Heart Lung Transplant. 2014;33(6):629–35.
Giavarini A, Chedid A, Bobrie G, et al. Acute cathecolamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart. 2013;99:1438–44.
Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, Lee J, Raissi S, Cheng W, Fontana G, Trento A. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol. 2008;51(12):1214–20.
Grauhan O, Siniawski H, Dandel M, Lehmkuhl H, Knosalla C, Pasic M, Weng YG, Hetzer R. Coronary atherosclerosis of the donor heart – impact on early graft failure. Eur J Cardiothorac Surg. 2007;32(4):634–8.
Hauptman PJ, O’Connor KJ, Wolf RE, McNeil BJ. Angiography of potential cardiac donors. J Am Coll Cardiol. 2001;37:1252–8.
Heng WL, Lai SH, Lim YP, Lim CH. The importance of histopathological examination for safety in heart valve transplantation – evaluation of histopathological findings in heart tissues from valve donors. J Cytol Histol. 2014;S4:003.
Hosenpud JD, Pantely GA, Morton MJ, Norman DJ, Cobanoglu AM, Starr A. Relation between recipient: donor body size match and hemodynamics three months after heart transplantation. J Heart Transplant. 1989;8(3):241–3.
Jochmans I, Pirenne J. Graft quality assessment in kidney transplantation: not an exact science yet! Curr Opin Organ Transplant. 2011;16(2):174–9.
Karamlou T, Shen I, Slater M, Crispell K, Chan B, Ravichandran P. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury. J Heart Lung Transplant. 2005;24(1):29–33.
Khush KK, Menza R, Nguyen J, Zaroff JG, Goldstein BA. Donor predictors of allograft use and recipient outcomes after heart transplantation. Circ Heart Fail. 2013;6(2):300–9.
Khush KK, Nguyen J, Goldstein BA, McGlothlin DP, Zaroff JG. Reliability of transthoracic echocardiogram interpretation in potential adult heart transplant donors. J Heart Lung Transplant. 2015;34(2):266–9.
Kransdorf EP, Stehlik J. Donor evaluation in heart transplantation: the end of the beginning. J Heart Lung Transplant. 2014;33:1105–13.
Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, Fowler M, Vagelos R, Perlroth MG, Robbins RC, Hunt SA. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant. 2007;7(10):2388–95.
Leone O, Gherardi S, Targa L, et al. Stress echocardiography as a gatekeeper to donation in aged marginal donor hearts: anatomic and pathologic correlations of abnormal stress echocardiography results. J Heart Lung Transplant. 2009;28:1141–9.
Li H, Tanaka K, Anzai H, Oeser B, Lai D, Kobashigawa JA, Tobis JM. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol. 2006;47(12):2470–6.
Lietz K, John R, Mancini DM, et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the waiting list. J Am Coll Cardiol. 2004;43:1553–61.
Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Meiser B, Yusen RD, Stehlik J. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report – 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33(10):996–1008.
Mackey-Bojack S, Roe S, Titus JL. Review of pathologic findings in remnant hearts following valve donation. J Forensic Sci. 2007;52(3):692–7.
Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant. 2000;19(5):496–503.
Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, et al. Frozen section evaluation of donor livers before transplantation. Transplantation. 1993;56:1403–9.
Mohamedali B, Bhat G, Tatooles A, Zelinger A. Neurogenic stress cardiomyopathy in heart donors. J Card Fail. 2014;20(3):207–11.
Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, Conte JV. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation. 2008;118(14 Suppl):S83–8.
Pérez López S, Otero Hernández J, Vázquez Moreno N, Escudero Augusto D, Álvarez Menéndez F, Astudillo González A. brain death effects on catecholamine levels and subsequent cardiac damage assessed in organ donors. J Heart Lung Transplant. 2009;28:815–20.
Reed RM, Netzer G, Hunsicker L, Mitchell BD, Rajagopal K, Scharf S, Eberlein M. Cardiac size and sex-matching in heart transplantation: size matters in matters of sex and the heart. JACC Heart Fail. 2014;2(1):73–83.
Roig E, Almenar L, Crespo-Leiro M, Segovia J, Mirabet S, Delgado J, Perez-Villa F, Luis Lambert J, Teresa Blasco M, Muniz J, rest of the participants of the Spanish Heart Transplantation R. Heart transplantation using allografts from older donors: multicenter study results. J Heart Lung Transplant. 2015;34(6):790–6.
Sardesal SH, et al. Phaechromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990;63:234–7.
Sethi GK, Lanauze P, Rosado LJ, Huston C, McCarthy MS, Butman S, Copeland JG. Clinical significance of weight difference between donor and recipient in heart transplantation. J Thorac Cardiovasc Surg. 1993;106(3):444–8.
Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, Zuckermann A. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant. 2012;31(4):387–97.
Stehlik J, Feldman DS, Brown RN, VanBakel AB, Russel SD, Ewald GA, Hagan ME, Folsom J, Kirklin JK. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant. 2010;29(3):291–8.
Stone RJ, Basso C, Baandrup UT, Bruneval P, Butany J, Gallagher PJ, Halushka MK, Miller DV, Padera RF, Radio SJ, Sheppard MN, Suvarna K, Tan CD, Thiene G, van der Wal AC, Veinot JP. Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol. 2012;21(1):2–16.
Van Geyt C, Van Wijk M, Bokhorst A, Beele H. Physical examination of the potential tissue donor, what do European tissue banks do? Clin Transplant. 2010;24(2):259–64.
Visser L, Holsboer E, Bokhorst AG, van Wijk MJ. The value of autopsy and other histological examinations for the safety of tissue transplantation. Cell Tissue Bank. 2012;13(1):37–46.
Warrens AN, Birch R, Collett D, Daraktchiev M, Dark JH, Galea G, Gronow K, Neuberger J, Hilton D, Whittle IR, Watson CJ, Advisory Committee on the Safety of Blood, Tissues and Organs, UK. Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation. 2012;93(4):348–53.
Weiss ES, Allen JG, Patel ND, Russell SD, Baumgartner WA, Shah AS, Conte JV. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. Circ Heart Fail. 2009;2(5):401–8.
Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years experience. Transpl Int. 2008;21:113–25.
Young JB. Age before beauty: the use of ‘older’ donor hearts for cardiac transplantation. J Heart Lung Transplant. 1999;18:488–91.
Zaroff JG, Babcock WD, Shiboski SC. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant. 2003;22:334–7.
Acknowledgements
Particular thanks go to Prof. Giorgio Arpesella, Head of Surgery Heart Transplant Unit of Bologna Sant’Orsola-Malpighi University Hospital until 2013, for his inspiration in creating the Adonhers project. Thanks also to Dr. Tonino Bombardini, Researcher of the Institute of Clinical Physiology-National Research Council, Pisa (Italy), for his assistance to Prof. Arpesella in setting up the project.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Leone, O., Potena, L., Foà, A., Zuckermann, A. (2016). Donor Selection Criteria: Clinical and Pathological Insights. In: Leone, O., Angelini, A., Bruneval, P., Potena, L. (eds) The Pathology of Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-46386-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-46386-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46384-1
Online ISBN: 978-3-319-46386-5
eBook Packages: MedicineMedicine (R0)